Skip to main content

Table 3 Meta-analysis results for circRNAs expression with clinicopathological features

From: CircRNAs as potential biomarkers for the clinicopathology and prognosis of glioma patients: a meta-analysis

  Tumor promoter Tumor suppressor
OR (95% CI) P value OR (95% CI) P value
Gender (M/W) 1.25 (0.99–1.58) 0.061 1.9 (1.02–3.51) 0.042
Age 1.32 (1.03–1.68) 0.026 0.46 (0.15–1.39) 0.014
Tumor size 3.48 (2.61–4.63) 0.000 0.49 (0.26–0.9) 0.022
Tumor grade (III + IV/I + II) 4.24 (3.26–5.52) 0.000 0.12(0.05–0.27) 0.000
Tumor location (Supra/Infra) 1.22 (0.87–1.70) 0.248 1.99 (0.7–5.62) 0.195
KPS 0.21(0.06–0.71) 0.012 0.98(0.19–4.99) 0.981
Family history of cancer (Y/N) 1.43 (0.92–2.21) 0.108 0.45 (0.1–1.98) 0.289
  1. OR odds ratio, CI confidence interval, M men, W women, Y yes, N no, the results are in bold if p < 0.05